Fig. 7From: Directional homing of glycosylation-modified bone marrow mesenchymal stem cells for bone defect repairThe result of Micro-CT for regenerated bone in femoral bone defect mouse model at 7 and 14 days. Representative images presenting A Post-injection micro-CT images for regenerated bone in femoral bone defect mouse model at 7 and 14 days; B The area of bone defect for femoral bone defect mouse model at 7 and 14 days after injection, *FuT7-BMSCs versus BMSCs p < 0.05, #FuT7-BMSCs vs Control p < 0.05; (C) Bone volume (BV)/Tissue volume (TV) ratio for femoral bone defect mouse model at 7 and 14 days after injection, *FuT7-BMSCs versus BMSCs p < 0.05, #FuT7-BMSCs vs Control p < 0.05Back to article page